The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus
Open accessAbstract
BACKGROUND: Poorly controlled cardiovascular risk factors are common. Evaluating whether physicians respond appropriately to poor risk factor control in patients may better reflect quality of care than measuring proportions of patients whose conditions are controlled. OBJECTIVES: To evaluate therapy modifications in response to poor control of hypertension, dyslipidemia, or diabetes in a large clinical population. DESIGN: Retrospective cohort study within an 18-month period in 2002 to 2003. SETTING: Kaiser Permanente of Northern California. PATIENTS: 253,238 adult members with poor control of 1 or more of these conditions. MEASUREMENTS: The authors assessed the proportion of patients with poor control who experienced a change in pharmacotherapy within 6 months, and they defined "appropriate care" as a therapy modification or return to control without therapy modification within 6 months. RESULTS: A total of 64% of patients experienced modifications in therapy for poorly controlled systolic blood pressure, 71% for poorly controlled diastolic blood pressure, 56% for poorly controlled low-density lipoprotein cholesterol level, and 66% for poorly controlled hemoglobin A1c level. Most frequent modifications were increases in number of drug classes (from 70% to 84%) and increased dosage (from 15% to 40%). An additional 7% to 11% of those with poorly controlled blood pressure, but only 3% to 4% of those with elevated low-density lipoprotein cholesterol level or hemoglobin A1c level, returned to control without therapy modification. Patients with more than 1 of the 3 conditions, higher baseline values, and target organ damage were more likely to receive "appropriate care." LIMITATIONS: Patient preferences and suboptimal adherence to therapy were not measured and may explain some failures to act. CONCLUSIONS: As an additional measure of the quality of care, measuring therapy modifications in response to poor control in a large population is feasible. Many patients with poorly controlled hypertension, dyslipidemia, or diabetes had their therapy modified and, thus, seemed to receive clinically "appropriate care" with this new quality measure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Primary Care: Is There Enough Time for Prevention?
Yarnall, K. S. H., Pollak, K. I., Østbye, T., Krause, K. M., & Michener, J. L. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.4.635 · Cited by 1,641 · cited 1×
“Proposed explanations for clinical inertia include physicians’ overestimation of their adherence to guidelines (12) or acceptance of elevated risk factor levels in their patients (30), lack of training on achieving therapeutic goals, possible lack of motivation in clinicians to treat asymptomatic chronic conditions (1…”
BackgroundPhillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160 · cited 1×
“For diabetes, concerns about hypoglycemia and patient or physician reluctance to initiate insulin therapy may be specific additional barriers to the implementation of more intensive control (36, 37).”
BackgroundA critical look at methods for handling missing covariates in epidemiologic regression analyses.
Greenland, S., & Finkle, W. D. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117592 · Cited by 891 · cited 1×
“Because of missing data on race or ethnicity (Table 1), we used complete case analysis for the multivariate models, which is less subject to bias than treating observations with missing race or ethnicity as a separate category (28).”
MethodEthnic disparities in diabetic complications in an insured population
Karter, A. J. (2002) · JAMA · doi:10.1001/jama.287.19.2519 · Cited by 840 · cited 3×
“Previous studies have documented the accuracy of the clinical databases used in our study for several diagnoses, including diabetes, coronary artery disease (CAD), and stroke (22, 23).”
BackgroundResultSelf-citationQuality of Diabetes Care in U.S. Academic Medical Centers
Grant, R. W., Buse, J. B., Meigs, J. B., & for the University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team (2005) · Diabetes Care · doi:10.2337/diacare.28.2.337 · Cited by 311
Cited by
Patient Medication Adherence: Measures in Daily Practice
Jimmy, B., & Jose, J. (2011) · Oman Medical Journal · doi:10.5001/omj.2011.38 · Cited by 956
Peek, M. E., Cargill, A., & Huang, E. S. (2007) · Medical Care Research and Review · doi:10.1177/1077558707305409 · Cited by 451
Fernandez, A., Schillinger, D., Warton, E. M., Adler, N., Moffet, H. H., Schenker, Y., Salgado, M. V., Ahmed, A., & Karter, A. J. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1507-6 · Cited by 334
Self-citationSchmittdiel, J. A., Uratsu, C. S., Karter, A. J., Heisler, M., Subramanian, U., Mangione, C. M., & Selby, J. V. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0554-8 · Cited by 239
Self-citationReasons for not intensifying medications: differentiating “clinical inertia” from appropriate care
Safford, M. M., Shewchuk, R., Qu, H., Williams, J. H., Estrada, C. A., Ovalle, F., & Allison, J. J. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0433-8 · Cited by 132
“potentially account for 80% of cardiovascular events, suggesting that it may be an appropriate focus for quality improvement and possibly public reporting.(5,6,8) Given its widespread prevalence, so-called “clinical inertia” is surprisingly poorly understood.”
Background
Metadata
- Authors
- Rodondi, N., Peng, T., Karter, A. J., Bauer, D. C., Vittinghoff, E., Tang, S., Pettitt, D., Kerr, E. A., & Selby, J. V.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-04-04
- Volume
- 144
- Issue
- 7
- Pages
- 475-484
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1992025401
- Cited by
- 206
- References
- 10
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus. https://app.cochat.ai/papers/10.7326/0003-4819-144-7-200604040-00006
- The paper
- Rodondi, N., Peng, T., Karter, A. J., Bauer, D. C., Vittinghoff, E., Tang, S., Pettitt, D., Kerr, E. A., & Selby, J. V. (2006). Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-144-7-200604040-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.